Cited by 49Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

The New Insulins—Lente, Ultralente, and Semilente

Open access
Murray, Ian, Wilson, Robert B.·1953·BMJ

Abstract

12 14 16 I8 20 22 24 DAYS OF TREATMENT FIG.2.-Fasting and noon blood sugars, glycosuria, ketosis, and dosage of lente insulin in a male patient aged 40.New case; control good.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.2.4844.1023

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The first 'peakless' basal insulin, ultralente, was developed during the 1950s by employing an extended zinc suspension without protamine.

    “The first ‘peakless’ basal insulin, known as ultralente (belonging to the lente family of insulins), was developed during the 1950s by employing an extended zinc suspension without protamine107.”

    From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [107]

    The introduction (page not supplied) identifies ultralente as a new Novo insulin available to the authors in 1952, and the Conclusions (page not supplied) report that its action lasted longer than protamine zinc insulin. Our copy does not establish that it was the first ‘peakless’ basal insulin or describe its formulation as an extended zinc suspension without protamine. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 3

  1. Lawrence, R. D., and Oakley, W. (1953). British Medical Journal, 1, 242.
  2. Lawrence, R. D., and Oakley, W. (1953). British Medical Journal, 1, 242.
  3. Nabarro, J. D. N., and Stowers, J. M. (1953). Proc. roy. Soc. Med. In press.

Cited by

Sorted by citations

Authors
Murray, I., & Wilson, R. B.
Venue
BMJ
Publisher
BMJ
Published
1953-11-07
Volume
2
Issue
4844
Pages
1023-1026
ISSN
  • 0007-1447 (ISSN-L)
  • 1468-5833
OpenAlex
W2093947620
Cited by
49
References
0
Citations by year
2025: 1 · 2022: 21 · 2021: 1 · 2013: 1
FWCI
12.00
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
insulin, lente insulin, ultralente insulin, insulin dose, blood glucose, glycosuria, ketosis, diabetes mellitus
MeSH terms
Humans, Insulin, Insulin, Lente

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review